CIK 0001020214
- Accelerated filer
CERUS CORP
Sign in to watch- Ticker
- CERS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 680262011
- Phone
- +1 925-288-6000
- Business address
- 1220 CONCORD AVENUE, SUITE 600, CONCORD, CA, 94520
- 4 Open-market buy Director bought 20,000 shares at $1.89 ($37,800)
- 4 Open-market buy Director bought 2,500 shares at $1.88 ($4,689)
- 4 Open-market sale Chief Financial Officer sold 42,555 shares at an average $1.99 ($84,882)
- 4 Open-market sale SVP Reg. & Quality sold 20,619 shares at an average $2.02 ($41,553)
- 4 Open-market sale Chief Legal Officer sold 35,284 shares at an average $2.02 ($71,107)
- 4 Open-market sale Chief Operating Officer sold 53,041 shares at an average $2.02 ($106,892)
- 4 Open-market sale President and CEO sold 125,926 shares at an average $2.04 ($256,377)
- 4 Open-market sale Chief Scientific Officer sold 28,427 shares at an average $2.02 ($57,288)
- 4 Open-market sale Chief Medical Officer sold 35,115 shares at an average $2.02 ($70,766)
- 4 Open-market sale Chief Medical Officer sold 29,378 shares at $2.40 ($70,457)
- 4 Grant or award SVP Reg. & Quality acquired 75,000 shares (grant or award)
- 4 Grant or award Chief Legal Officer acquired 160,000 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 240,000 shares (grant or award)
- 4 Grant or award President and CEO acquired 575,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 200,000 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 90,000 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 160,000 shares (grant or award)
- 4 Open-market buy Director bought 10,000 shares at $1.62 ($16,200)
- 4 Open-market buy Director bought 7,500 shares at $1.69 ($12,638)
- 4 Open-market buy Director bought 10,000 shares at $1.72 ($17,151)
Page 5 of 36 · 701 filings